ExtenZe 600 mg — Class I drug recall D-1339-2014
Terminated recall by Schindele Enterprises dba Midwest Wholesale, reported 2014-05-28, distributed in CA, CT, FL, GA, IA, IL, LA, MD…. Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of
| Recall number | D-1339-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Schindele Enterprises dba Midwest Wholesale, Nixa, MO, United States |
| Recall initiated | 2014-01-09 |
| Classified | 2014-05-20 |
| Reported by FDA | 2014-05-28 |
| Terminated | 2015-02-03 |
| Distributed | CA, CT, FL, GA, IA, IL, LA, MD, NV, NY, PA, TX, WI |
| Quantity | 57 boxes |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 05/16, 0512058 |
Product
ExtenZe 600 mg, 30 tablet box, Manufactured for: Biotab Nutraceuticals, Inc., Pasadena, CA.
Reason for recall
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1339-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.